Considerations for the rational design of a Chlamydia vaccine

References

• World Health Organization. Progress report of the implementation of the global strategy for prevention and control of sexually transmitted infections: 2006–2012. 2015. Available at: http://apps.who.int/iris/bitstream/10665/183117/1/9789241508841_eng.pdf?ua=1 (accessed 22 Nov 2016)
   Google Scholar
• Peipert JF. Clinical practice. Genital chlamydial infections. N Engl J Med 2003; 349:2424-30; PMID:14681509; https://doi.org/http://dx.doi.org/10.1056/NEJMcp030542
   PubMed Web of Science ®Google Scholar
• Brunham RC, Gottlieb SL, Paavonen J. Pelvic inflammatory disease. N Engl J Med 2015; 372:2039-48; PMID:25992748; https://doi.org/http://dx.doi.org/10.1056/NEJMra1411426
   PubMed Web of Science ®Google Scholar
• Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, Goeman J, Behets F, Batter V, Alary M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. Aids 1993; 7:95-102; PMID:8442924; https://doi.org/http://dx.doi.org/10.1097/00002030-199301000-00015
   PubMed Web of Science ®Google Scholar
• Samoff E, Koumans EH, Markowitz LE, Sternberg M, Sawyer MK, Swan D, Papp JR, Black CM, Unger ER. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol 2005; 162:668-75; PMID:16120706; https://doi.org/http://dx.doi.org/10.1093/aje/kwi262
   PubMed Web of Science ®Google Scholar
• Brunham RC, Rappuoli R. Chlamydia trachomatis control requires a vaccine. Vaccine 2013; 31:1892-7; PMID:23375977; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2013.01.024
   PubMed Web of Science ®Google Scholar
• World Health Organization. Report of the Third Meeting of the WHO Alliance for the Global Elimination of Trachoma. 1998. Available at: http://www.who.int/pbd/publications/trachoma/en/get_oct1998.pdf (accessed 22 Nov 2016)
   Google Scholar
• Cohen CR, Koochesfahani KM, Meier AS, Shen C, Karunakaran K, Ondondo B, Kinyari T, Mugo NR, Nguti R, Brunham RC. Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon- gamma. J Infect Dis 2005; 192:591-9; PMID:16028127; https://doi.org/http://dx.doi.org/10.1086/432070
   PubMed Web of Science ®Google Scholar
• Brunham RC, Kuo CC, Cles L, Holmes KK. Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun 1983; 39:1491-4; PMID:6840846
   PubMed Web of Science ®Google Scholar
• Gondek DC, Olive AJ, Stary G, Starnbach MN. CD4+ T cells are necessary and sufficient to confer protection against Chlamydia trachomatis infection in the murine upper genital tract. J Immunol 2012; 189:2441-9; https://doi.org/http://dx.doi.org/10.4049/jimmunol.1103032
   PubMed Web of Science ®Google Scholar
• Farris CM, Morrison RP. Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model. Infect Immun 2011; 79:986-96; PMID:21078844; https://doi.org/http://dx.doi.org/10.1128/IAI.00881-10
   PubMed Web of Science ®Google Scholar
• Yu H, Karunakaran KP, Jiang X, Shen C, Andersen P, Brunham RC. Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice. Infect Immun 2012; 80:1510-8; PMID:22290151; https://doi.org/http://dx.doi.org/10.1128/IAI.06338-11
   PubMed Web of Science ®Google Scholar
• Vlcek KR, Li W, Manam S, Zanotti B, Nicholson BJ, Ramsey KH, Murthy AK. The contribution of Chlamydia-specific CD8(+) T cells to upper genital tract pathology. Immunol Cell Biol 2016; 94:208-12; PMID:26323581; https://doi.org/http://dx.doi.org/10.1038/icb.2015.74
   PubMed Web of Science ®Google Scholar
• Olivares-Zavaleta N, Whitmire WM, Kari L, Sturdevant GL, Caldwell HD. CD8+ T cells define an unexpected role in live-attenuated vaccine protective immunity against Chlamydia trachomatis infection in macaques. J Immunol 2014; 192:4648-54; https://doi.org/http://dx.doi.org/10.4049/jimmunol.1400120
   PubMed Web of Science ®Google Scholar
• Morrison SG, Morrison RP. A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J Immunol 2005; 175:7536-42; https://doi.org/http://dx.doi.org/10.4049/jimmunol.175.11.7536
   PubMed Web of Science ®Google Scholar
• Naglak EK, Morrison SG, Morrison RP. Gamma interferon is required for optimal antibody-mediated immunity against genital chlamydia infection. Infect Immun 2016; 84:3232-3242; PMID:27600502; https://doi.org/https://doi.org/10.1128/IAI.00749-16
   Google Scholar
• Olsen AW, Follmann F, Erneholm K, Rosenkrands I, Andersen P. Protection against chlamydia trachomatis infection and upper genital tract pathological changes by vaccine-promoted neutralizing antibodies directed to the VD4 of the major outer membrane protein. J Infect Dis 2015; 212:978-89; PMID:25748320; https://doi.org/http://dx.doi.org/10.1093/infdis/jiv137
   PubMed Web of Science ®Google Scholar
• Hafner L, Beagley K, Timms P. Chlamydia trachomatis infection: host immune responses and potential vaccines. Mucosal Immunol 2008; 1:116-30; PMID:19079169; https://doi.org/http://dx.doi.org/10.1038/mi.2007.19
   PubMed Web of Science ®Google Scholar
• Marinova D, Gonzalo-Asensio J, Aguilo N, Martin C. Recent developments in tuberculosis vaccines. Exp Rev Vaccines 2013; 12:1431-48; PMID:24195481; https://doi.org/http://dx.doi.org/10.1586/14760584.2013.856765
   PubMed Web of Science ®Google Scholar
• Roth K, Ferreira VH, Kaushic C. HSV-2 vaccine: current state and insights into development of a vaccine that targets genital mucosal protection. Microb Pathog 2013; 58:45-54; PMID:23159485; https://doi.org/http://dx.doi.org/10.1016/j.micpath.2012.11.001
   PubMed Web of Science ®Google Scholar
• Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Lockhart S, Shea JE, McClain JB, Hussey GD, Hanekom WA, et al. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 2013; 381:1021-8; PMID:23391465; https://doi.org/http://dx.doi.org/10.1016/S0140-6736(13)60177-4
   PubMed Web of Science ®Google Scholar
• Kraan H, Vrieling H, Czerkinsky C, Jiskoot W, Kersten G, Amorij JP. Buccal and sublingual vaccine delivery. J Control Release 2014; 190:580-92; PMID:24911355; https://doi.org/http://dx.doi.org/10.1016/j.jconrel.2014.05.060
   PubMed Web of Science ®Google Scholar
• Stary G, Olive A, Radovic-Moreno AF, Gondek D, Alvarez D, Basto PA, Perro M, Vrbanac VD, Tager AM, Shi J, et al. VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells. Science 2015; 348:aaa8205; PMID:26089520
   PubMed Web of Science ®Google Scholar
• Johnson RM, Brunham RC. Tissue-Resident T Cells as the Central Paradigm of Chlamydia Immunity. Infect Immun 2016; 84:868-73; PMID:26787715; https://doi.org/http://dx.doi.org/10.1128/IAI.01378-15
   PubMed Web of Science ®Google Scholar
• Lorenzen E, Follmann F, Boje S, Erneholm K, Olsen AW, Agerholm JS, Jungersen G, Andersen P. Intramuscular priming and intranasal boosting induce strong genital immunity through secretory IgA in minipigs infected with chlamydia trachomatis. Front Immunol 2015; 6:628; PMID:26734002; https://doi.org/http://dx.doi.org/10.3389/fimmu.2015.00628
   PubMed Web of Science ®Google Scholar
• Murthy AK, Chaganty BK, Li W, Guentzel MN, Chambers JP, Seshu J, Zhong G, Arulanandam BP. A limited role for antibody in protective immunity induced by rCPAF and CpG vaccination against primary genital Chlamydia muridarum challenge. FEMS Immunol Med Microbiol 2009; 55:271-9; PMID:19281569; https://doi.org/http://dx.doi.org/10.1111/j.1574-695X.2008.00517.x
   PubMedGoogle Scholar
• Finco O, Frigimelica E, Buricchi F, Petracca R, Galli G, Faenzi E, Meoni E, Bonci A, Agnusdei M, Nardelli F, et al. Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines. Proc Natl Acad Sci U S A 2011; 108:9969-74; PMID:21628568; https://doi.org/http://dx.doi.org/10.1073/pnas.1101756108
   PubMed Web of Science ®Google Scholar
• Karunakaran KP, Rey-Ladino J, Stoynov N, Berg K, Shen C, Jiang X, Gabel BR, Yu H, Foster LJ, Brunham RC. Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia. J Immunol 2008; 180:2459-65; https://doi.org/http://dx.doi.org/10.4049/jimmunol.180.4.2459
   PubMed Web of Science ®Google Scholar
• Meoni E, Faenzi E, Frigimelica E, Zedda L, Skibinski D, Giovinazzi S, Bonci A, Petracca R, Bartolini E, Galli G, et al. CT043, a protective antigen that induces a CD4+ Th1 response during Chlamydia trachomatis infection in mice and humans. Infect Immun 2009; 77:4168-76; PMID:19596772; https://doi.org/http://dx.doi.org/10.1128/IAI.00344-09
   PubMed Web of Science ®Google Scholar
• Bulir DC, Liang S, Lee A, Chong S, Simms E, Stone C, Kaushic C, Ashkar A, Mahony JB. Immunization with chlamydial type III secretion antigens reduces vaginal shedding and prevents fallopian tube pathology following live C. muridarum challenge. Vaccine 2016; 34:3979-85; PMID:27325352; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2016.06.046
   PubMed Web of Science ®Google Scholar
• Linhares IM, Witkin SS. Immunopathogenic consequences of Chlamydia trachomatis 60 kDa heat shock protein expression in the female reproductive tract. Cell Stress Chaperones 2010; 15:467-73; PMID:20182835; https://doi.org/http://dx.doi.org/10.1007/s12192-010-0171-4
   PubMed Web of Science ®Google Scholar
• Belland RJ, Nelson DE, Virok D, Crane DD, Hogan D, Sturdevant D, Beatty WL, Caldwell HD. Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation. Proc Natl Acad Sci U S A 2003; 100:15971-6; PMID:14673075; https://doi.org/http://dx.doi.org/10.1073/pnas.2535394100
   PubMed Web of Science ®Google Scholar
• Shi L, North R, Gennaro ML. Effect of growth state on transcription levels of genes encoding major secreted antigens of Mycobacterium tuberculosis in the mouse lung. Infect Immun 2004; 72:2420-4; PMID:15039373; https://doi.org/http://dx.doi.org/10.1128/IAI.72.4.2420-2424.2004
   PubMed Web of Science ®Google Scholar
• Aagaard C, Hoang T, Dietrich J, Cardona PJ, Izzo A, Dolganov G, Schoolnik GK, Cassidy JP, Billeskov R, Andersen P. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nature medicine 2011; 17:189-94; PMID:21258338; https://doi.org/http://dx.doi.org/10.1038/nm.2285
   PubMed Web of Science ®Google Scholar
• Reece ST, Nasser-Eddine A, Dietrich J, Stein M, Zedler U, Schommer-Leitner S, Ottenhoff TH, Andersen P, Kaufmann SH. Improved long-term protection against Mycobacterium tuberculosis Beijing/W in mice after intra-dermal inoculation of recombinant BCG expressing latency associated antigens. Vaccine 2011; 29:8740-4; PMID:21871515; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2011.07.144
   PubMed Web of Science ®Google Scholar